Cushing's syndrome and bone mineral density: lowest Z scores in young patients.
BACKGROUND
Patients with Cushing's syndrome have a high prevalence of osteoporotic fractures. Little is known about factors determining bone mineral density (BMD) in these patients.


OBJECTIVE
To evaluate which factors influence BMD at the time of diagnosis of Cushing's syndrome.


METHODS
In 77 consecutive patients with Cushing's syndrome with a median age of 41.1 (interquartile range 31.1 to 52.2) years we measured BMD of the lumbar spine and the femoral neck at the time of diagnosis. From the medical records we obtained information on possible predictors of BMD. We compared BMD with a reference population by means of the Z score. Adjustment for other variables than age and sex was made with linear regression models.


RESULTS
Patients with Cushing's syndrome had a low Z score in both the lumbar spine (-1.07 SD (95% CI -1.43 to -0.71 SD )) and in the femoral neck (-0.81 SD (95% CI -1.06 to -0.55 SD )). 82% of patients had osteopenia at one or both sites (T score lower than -1 SD ), including 31% with osteoporosis (T score -2.5 SD or lower). The main determinant of the Z score at both sites and for both sexes was age. Z score increased by about 0.4 SD per decade. 81% of patients.
van der Eerden
A W
AW
Department of Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
den Heijer
M
M
Oyen
W J
WJ
Hermus
A R
AR
D015502:Absorptiometry, Photon; D000328:Adult; D015519:Bone Density / Q000187:drug effects*; D001862:Bone Resorption / Q000139:chemically induced; D003480:Cushing Syndrome / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D005260:Female; D005272:Femur Neck / Q000000981:diagnostic imaging / Q000473:pathology; D050723:Fractures, Bone / Q000209:etiology*; D005938:Glucocorticoids / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D016014:Linear Models; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D010024:Osteoporosis / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use
D005938:Glucocorticoids; D011241:Prednisone; D006854:Hydrocortisone